Low dose of lipopolysaccharide pretreatment can alleviate the inflammatory response in wound infection mouse model

Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Methods: Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial lon- gitudinal incision w...

Full description

Saved in:
Bibliographic Details
Published inChinese journal of traumatology Vol. 19; no. 4; pp. 193 - 198
Main Authors Wang, Dong, Liu, Yang, Zhao, Yan-Rui, Zhou, Jun-Lin
Format Journal Article
LanguageEnglish
Published China Elsevier B.V 01.08.2016
Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing 100020, China
Elsevier
Subjects
Online AccessGet full text
ISSN1008-1275
DOI10.1016/j.cjtee.2016.06.001

Cover

Loading…
Abstract Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Methods: Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial lon- gitudinal incision was made and infected with different bacteria. Results: It is showed that 0.5 mg/kg/time ofLPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa, or Escherichia coil compared with doses of 0.25 mg/kg/time, 1 mg/ kg/time, and 1.5 mg/kg/time. Conclusions: LPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
AbstractList To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial longitudinal incision was made and infected with different bacteria. It is showed that 0.5 mg/kg/time of LPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa, or Escherichia coli compared with doses of 0.25 mg/kg/time, 1 mg/kg/time, and 1.5 mg/kg/time. LPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Methods: Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial lon- gitudinal incision was made and infected with different bacteria. Results: It is showed that 0.5 mg/kg/time ofLPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa, or Escherichia coil compared with doses of 0.25 mg/kg/time, 1 mg/ kg/time, and 1.5 mg/kg/time. Conclusions: LPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Methods: Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial longitudinal incision was made and infected with different bacteria. Results: It is showed that 0.5 mg/kg/time of LPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa, or Escherichia coli compared with doses of 0.25 mg/kg/time, 1 mg/kg/time, and 1.5 mg/kg/time. Conclusions: LPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
Purpose:To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo.Methods:Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial longitudinal incision was made and infected with different bacteria.Results:It is showed that 0.5 mg/kg/time of LPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus,methicillin-sensitive S.aureus,Pseudomonas aeruginosa,or Escherichia coli compared with doses of 0.25 mg/kg/time,1 mg/kg/time,and 1.5 mg/kg/time.Conclusions:LP5 pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time,and meanwhile it does not damage organs' function.
Author DongWang Yang Liu Yan-Rui Zhao Jun-Lin Zhou
AuthorAffiliation Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing 100020, China
AuthorAffiliation_xml – name: Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing 100020, China
Author_xml – sequence: 1
  givenname: Dong
  surname: Wang
  fullname: Wang, Dong
– sequence: 2
  givenname: Yang
  surname: Liu
  fullname: Liu, Yang
– sequence: 3
  givenname: Yan-Rui
  surname: Zhao
  fullname: Zhao, Yan-Rui
– sequence: 4
  givenname: Jun-Lin
  surname: Zhou
  fullname: Zhou, Jun-Lin
  email: 13240718193@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28935116$$D View this record in MEDLINE/PubMed
BookMark eNqFUU1v1DAQzaGIfsAvQEIWNw672EnWsQ8cUFWg0kpc4GxNnPGuo8QOtrer3V-P07Q9cKk0kuWZ9948vbkuLpx3WBQfGF0zyviXfq37hLgu82dNc1F2UVwxSsWKlc3msriOsae0LummeVtclkJWG8b4VRG2_kg6H5F4QwY7-ckPpwha7yHYDskUMAWENKJLRIMjMAz4YCEhSXsk1pkBxhGSDycSME7exblLjv7gunmMOlnvyOgPeTD6Dod3xRsDQ8T3T-9N8ef73e_bn6vtrx_3t9-2K11LkVacYQu60xXHWhrDmDDG1JK2WGvRlaUEaDWthWhbYZoGq02Zq9Yl5VUlJK1uivtFt_PQqynYEcJJebDqseHDTkFIVg-oOJTSUGk2LXZ1w2XbSKg0a5nRNdKWZa3Pi9YRnAG3U70_BJfdq_Nex_NZ4Zw8rSktM_bjgp0O7Yjdy-bn0DOgWgA6-BgDmhcIo2o-p-rV4znVLKpoLjpbkP-xtE0wh5sC2OEV7teFiznvB4tBRW3RaexsyAfKgdhX-J-edu-92_21OYBny5xLISTnTfUPkZfMDQ
CitedBy_id crossref_primary_10_1073_pnas_2412423121
crossref_primary_10_3390_cells11172693
crossref_primary_10_1111_apm_13119
crossref_primary_10_2147_IDR_S315105
crossref_primary_10_1007_s12035_023_03483_9
crossref_primary_10_3390_ijms252111773
crossref_primary_10_1002_adhm_202302797
crossref_primary_10_3389_fncel_2022_993019
crossref_primary_10_31083_j_jin2102049
crossref_primary_10_3389_fnbeh_2021_659679
crossref_primary_10_3390_ijms20092293
crossref_primary_10_1007_s11999_0000000000000232
Cites_doi 10.1007/978-3-319-11038-7_2
10.2147/DDDT.S71957
10.1016/j.ecoenv.2013.09.039
10.1098/rsif.2010.0294
10.1007/978-1-4419-0298-6_23
10.1016/j.ijfoodmicro.2011.12.035
10.3389/fimmu.2013.00109
10.7603/s40681-015-0005-x
10.1021/jf505531w
10.1097/SHK.0b013e318162c190
10.3855/jidc.4482
10.4103/0972-124X.107466
10.1371/journal.pone.0124001
10.1002/pros.22983
10.1128/IAI.68.6.3748-3753.2000
10.1007/s00268-014-2922-3
10.2106/JBJS.K.01672
10.1517/14712598.2013.838556
ContentType Journal Article
Copyright 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Copyright © 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V. All rights reserved.
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
– notice: Copyright © 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V. All rights reserved.
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
2B.
4A8
92I
93N
PSX
TCJ
DOA
DOI 10.1016/j.cjtee.2016.06.001
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList


MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
DocumentTitleAlternate Low dose of lipopolysaccharide pretreatment can alleviate the inflammatory response in wound infection mouse model
EndPage 198
ExternalDocumentID oai_doaj_org_article_6a29f09f5bed4769b79a3c1b1fc4e0b1
zhcszz_e201604002
28935116
10_1016_j_cjtee_2016_06_001
S1008127516301894
669889667
Genre Journal Article
GroupedDBID ---
--K
-05
-0E
-SE
-S~
.~1
0R~
0SF
1B1
1~.
1~5
29B
2B.
2C~
2RA
4.4
40I
457
4G.
53G
5GY
5VR
5VS
6I.
6PF
7-5
71M
92F
92I
92L
92M
93N
93R
9D9
9DE
AACTN
AAEDT
AAEDW
AAFTH
AALRI
AAQFI
AAWTL
AAXUO
ABBQC
ABKZE
ABMAC
ACGFS
ADEZE
ADMUD
ADRAZ
AEKER
AEXQZ
AFTJW
AFUIB
AGHFR
AGYEJ
AITUG
AJRQY
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
CAJEE
CAJUS
CCEZO
CHBEP
CIEJG
CQIGP
CS3
CW9
DIK
EBS
EJD
EP2
EP3
FA0
FDB
FNPLU
GBLVA
GROUPED_DOAJ
HYE
HZ~
IPNFZ
J1W
JUIAU
KQ8
M41
M48
MO0
N9A
NCXOZ
O-L
O9-
OK1
OVD
OZT
P-8
P-9
PC.
Q--
Q-4
Q38
R-E
RIG
ROL
RPM
RT5
S..
SDF
SES
SSZ
T8U
TCJ
TEORI
TGQ
U1F
U1G
U5E
U5O
W2D
W91
WFFXF
~N2
~WA
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEUPX
AFPUW
AIGII
AKBMS
AKRWK
AKYEP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
4A8
PSX
ID FETCH-LOGICAL-c498t-61ebacdc36e49ff118fff490be4c8d229aabc0488bb8f77e3523524c206338903
IEDL.DBID M48
ISSN 1008-1275
IngestDate Wed Aug 27 01:30:27 EDT 2025
Thu May 29 03:59:40 EDT 2025
Thu Jan 02 23:12:23 EST 2025
Tue Jul 01 02:59:12 EDT 2025
Thu Apr 24 23:08:21 EDT 2025
Thu Jul 20 20:01:22 EDT 2023
Wed Feb 14 10:15:57 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Surgical wound infection
Inflammatory reaction
Lipopolysaccharides
Language English
License This is an open access article under the CC BY-NC-ND license.
https://www.elsevier.com/tdm/userlicense/1.0
http://creativecommons.org/licenses/by-nc-nd/4.0
Copyright © 2016 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University. Production and hosting by Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c498t-61ebacdc36e49ff118fff490be4c8d229aabc0488bb8f77e3523524c206338903
Notes Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment dose in vivo. Methods: Mice were pretreated with LPS of different doses at 48 and 24 h before femoral medial lon- gitudinal incision was made and infected with different bacteria. Results: It is showed that 0.5 mg/kg/time ofLPS pretreatment can significantly alleviate the inflammation in mouse model infected with methicillin-resistances Staphylococcus aureus, methicillin-sensitive S. aureus, Pseudomonas aeruginosa, or Escherichia coil compared with doses of 0.25 mg/kg/time, 1 mg/ kg/time, and 1.5 mg/kg/time. Conclusions: LPS pretreatment can alleviate the inflammation in mouse model and the optimal dose is 0.5 mg/kg/time, and meanwhile it does not damage organs' function.
Lipopolysaccharides;Inflammatory reaction;Surgical wound infection
50-1115/R
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S1008127516301894
PMID 28935116
PageCount 6
ParticipantIDs doaj_primary_oai_doaj_org_article_6a29f09f5bed4769b79a3c1b1fc4e0b1
wanfang_journals_zhcszz_e201604002
pubmed_primary_28935116
crossref_primary_10_1016_j_cjtee_2016_06_001
crossref_citationtrail_10_1016_j_cjtee_2016_06_001
elsevier_sciencedirect_doi_10_1016_j_cjtee_2016_06_001
chongqing_primary_669889667
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-08-01
PublicationDateYYYYMMDD 2016-08-01
PublicationDate_xml – month: 08
  year: 2016
  text: 2016-08-01
  day: 01
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Chinese journal of traumatology
PublicationTitleAlternate Chinese Journal of Traumatology(English Edition)
PublicationTitle_FL Chinese Journal of Traumatology
PublicationYear 2016
Publisher Elsevier B.V
Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing 100020, China
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Department of Orthopedics, Beijing Chao-Yang Hospital, Beijing 100020, China
– name: Elsevier
References Rayhane, Fitting, Lortholary (bib4) 2000; 68
Xue, Zheng, Gong (bib19) 2015; 10
Jain, Suklabaidya, Das (bib20) 2015; 75
Zhou, Zhang, Huang (bib3) 2015; 35
Li, Liu, Ma (bib2) 2015; 27
Lin, Fan, Maa (bib5) 2015; 5
Dijkstra, Larkin, Anthony (bib13) 2011; 8
Kokudo, Uldry, Demartines (bib10) 2015; 39
Bao, Cao, Zhou (bib7) 2015; 63
Matsuura (bib1) 2013; 4
Dhir (bib17) 2013; 17
Mytilinaios, Salih, Schofield (bib12) 2012; 154
Arciola, Campoccia, Ehrlich (bib18) 2015; 830
Wang (bib6) 2013; 13
Zhou, Ma (bib16) 2015; 9
Naik, Dubey (bib11) 2013; 98
Inman (bib21) 2009; 649
Choi, Kim, Lee (bib9) 2014; 8
Mao, Xie (bib14) 2007; 13
Wheeler, Lahni, Denenberg (bib8) 2008; 30
Ovaska, Mäkinen, Madanat (bib15) 2013; 95
Zhou (10.1016/j.cjtee.2016.06.001_bib3) 2015; 35
Wheeler (10.1016/j.cjtee.2016.06.001_bib8) 2008; 30
Zhou (10.1016/j.cjtee.2016.06.001_bib16) 2015; 9
Matsuura (10.1016/j.cjtee.2016.06.001_bib1) 2013; 4
Rayhane (10.1016/j.cjtee.2016.06.001_bib4) 2000; 68
Lin (10.1016/j.cjtee.2016.06.001_bib5) 2015; 5
Wang (10.1016/j.cjtee.2016.06.001_bib6) 2013; 13
Choi (10.1016/j.cjtee.2016.06.001_bib9) 2014; 8
Kokudo (10.1016/j.cjtee.2016.06.001_bib10) 2015; 39
Arciola (10.1016/j.cjtee.2016.06.001_bib18) 2015; 830
Dijkstra (10.1016/j.cjtee.2016.06.001_bib13) 2011; 8
Xue (10.1016/j.cjtee.2016.06.001_bib19) 2015; 10
Li (10.1016/j.cjtee.2016.06.001_bib2) 2015; 27
Ovaska (10.1016/j.cjtee.2016.06.001_bib15) 2013; 95
Dhir (10.1016/j.cjtee.2016.06.001_bib17) 2013; 17
Jain (10.1016/j.cjtee.2016.06.001_bib20) 2015; 75
Bao (10.1016/j.cjtee.2016.06.001_bib7) 2015; 63
Naik (10.1016/j.cjtee.2016.06.001_bib11) 2013; 98
Mytilinaios (10.1016/j.cjtee.2016.06.001_bib12) 2012; 154
Inman (10.1016/j.cjtee.2016.06.001_bib21) 2009; 649
Mao (10.1016/j.cjtee.2016.06.001_bib14) 2007; 13
References_xml – volume: 4
  start-page: 109
  year: 2013
  ident: bib1
  article-title: Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity
  publication-title: Front Immunol
– volume: 13
  start-page: 19
  year: 2007
  end-page: 20
  ident: bib14
  article-title: An experimental animal model for infected wound of maxillofacial areas
  publication-title: J Hainan Med Univ
– volume: 830
  start-page: 29
  year: 2015
  end-page: 46
  ident: bib18
  article-title: Biofilm-based implant infections in orthopaedics
  publication-title: Adv Exp Med Biol
– volume: 8
  start-page: 1941
  year: 2014
  end-page: 1953
  ident: bib9
  article-title: Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways
  publication-title: Drug Des Dev Ther
– volume: 5
  start-page: 5
  year: 2015
  ident: bib5
  article-title: Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation
  publication-title: Biomedicine
– volume: 8
  start-page: 334
  year: 2011
  end-page: 344
  ident: bib13
  article-title: Diamagnetic levitation enhances growth of liquid bacterial cultures by increasing oxygen availability
  publication-title: J R Soc Interface
– volume: 68
  start-page: 3748
  year: 2000
  end-page: 3753
  ident: bib4
  article-title: Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection
  publication-title: Infect Immun
– volume: 154
  start-page: 169
  year: 2012
  end-page: 176
  ident: bib12
  article-title: Growth curve prediction from optical density data
  publication-title: Int J Food Microbiol
– volume: 39
  start-page: 1185
  year: 2015
  end-page: 1192
  ident: bib10
  article-title: Risk factors for incisional and organ space surgical site infections after liver resection are different
  publication-title: World J Surg
– volume: 95
  start-page: 348
  year: 2013
  end-page: 353
  ident: bib15
  article-title: Risk factors for deep surgical site infection following operative treatment of ankle fractures
  publication-title: J Bone Jt Surg Am
– volume: 63
  start-page: 2811
  year: 2015
  end-page: 2819
  ident: bib7
  article-title: Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes
  publication-title: J Agric Food Chem
– volume: 30
  start-page: 267
  year: 2008
  end-page: 273
  ident: bib8
  article-title: Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis
  publication-title: Shock
– volume: 27
  start-page: 81
  year: 2015
  end-page: 85
  ident: bib2
  article-title: Unfractionated heparin inhibits lipopolysaccharide-induced expression of granulocyte colony-stimulating factor in human endothelial cells through Toll-like receptor 4 signaling pathway
  publication-title: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
– volume: 10
  start-page: e0124001
  year: 2015
  ident: bib19
  article-title: Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia
  publication-title: PLoS One
– volume: 75
  start-page: 1020
  year: 2015
  end-page: 1033
  ident: bib20
  article-title: TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells
  publication-title: Prostate
– volume: 13
  start-page: 1639
  year: 2013
  end-page: 1641
  ident: bib6
  article-title: Monophosphoryl lipid A is a lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology
  publication-title: Expert Opin Biol Ther
– volume: 98
  start-page: 1
  year: 2013
  end-page: 7
  ident: bib11
  article-title: Lead resistant bacteria: lead resistance mechanisms, their applications in lead bioremediation and biomonitoring
  publication-title: Ecotoxicol Environ Saf
– volume: 649
  start-page: 300
  year: 2009
  end-page: 309
  ident: bib21
  article-title: Innate immunity of spondyloarthritis: the role of toll-like receptors
  publication-title: Adv Exp Med Biol
– volume: 35
  start-page: 6
  year: 2015
  end-page: 11
  ident: bib3
  article-title: Role of RAGE in lipopolysaccharide-induced cytoskeletal changes in mouse pulmonary microvascular endothelial cells
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
– volume: 9
  start-page: 182
  year: 2015
  end-page: 189
  ident: bib16
  article-title: Cost-benefit analysis of craniocerebral surgical site infection control in tertiary hospitals in China
  publication-title: J Infect Dev Ctries
– volume: 17
  start-page: 5
  year: 2013
  end-page: 11
  ident: bib17
  article-title: Biofilm and dental implant: the microbial link
  publication-title: J Indian Soc Periodontol
– volume: 830
  start-page: 29
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib18
  article-title: Biofilm-based implant infections in orthopaedics
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-3-319-11038-7_2
– volume: 8
  start-page: 1941
  year: 2014
  ident: 10.1016/j.cjtee.2016.06.001_bib9
  article-title: Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways
  publication-title: Drug Des Dev Ther
  doi: 10.2147/DDDT.S71957
– volume: 98
  start-page: 1
  year: 2013
  ident: 10.1016/j.cjtee.2016.06.001_bib11
  article-title: Lead resistant bacteria: lead resistance mechanisms, their applications in lead bioremediation and biomonitoring
  publication-title: Ecotoxicol Environ Saf
  doi: 10.1016/j.ecoenv.2013.09.039
– volume: 8
  start-page: 334
  year: 2011
  ident: 10.1016/j.cjtee.2016.06.001_bib13
  article-title: Diamagnetic levitation enhances growth of liquid bacterial cultures by increasing oxygen availability
  publication-title: J R Soc Interface
  doi: 10.1098/rsif.2010.0294
– volume: 649
  start-page: 300
  year: 2009
  ident: 10.1016/j.cjtee.2016.06.001_bib21
  article-title: Innate immunity of spondyloarthritis: the role of toll-like receptors
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-1-4419-0298-6_23
– volume: 154
  start-page: 169
  year: 2012
  ident: 10.1016/j.cjtee.2016.06.001_bib12
  article-title: Growth curve prediction from optical density data
  publication-title: Int J Food Microbiol
  doi: 10.1016/j.ijfoodmicro.2011.12.035
– volume: 4
  start-page: 109
  year: 2013
  ident: 10.1016/j.cjtee.2016.06.001_bib1
  article-title: Structural modifications of bacterial lipopolysaccharide that facilitate gram-negative bacteria evasion of host innate immunity
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2013.00109
– volume: 5
  start-page: 5
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib5
  article-title: Lipopolysaccharide-promoted proliferation of Caco-2 cells is mediated by c-Src induction and ERK activation
  publication-title: Biomedicine
  doi: 10.7603/s40681-015-0005-x
– volume: 63
  start-page: 2811
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib7
  article-title: Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes
  publication-title: J Agric Food Chem
  doi: 10.1021/jf505531w
– volume: 30
  start-page: 267
  year: 2008
  ident: 10.1016/j.cjtee.2016.06.001_bib8
  article-title: Induction of endotoxin tolerance enhances bacterial clearance and survival in murine polymicrobial sepsis
  publication-title: Shock
  doi: 10.1097/SHK.0b013e318162c190
– volume: 27
  start-page: 81
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib2
  article-title: Unfractionated heparin inhibits lipopolysaccharide-induced expression of granulocyte colony-stimulating factor in human endothelial cells through Toll-like receptor 4 signaling pathway
  publication-title: Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
– volume: 9
  start-page: 182
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib16
  article-title: Cost-benefit analysis of craniocerebral surgical site infection control in tertiary hospitals in China
  publication-title: J Infect Dev Ctries
  doi: 10.3855/jidc.4482
– volume: 17
  start-page: 5
  year: 2013
  ident: 10.1016/j.cjtee.2016.06.001_bib17
  article-title: Biofilm and dental implant: the microbial link
  publication-title: J Indian Soc Periodontol
  doi: 10.4103/0972-124X.107466
– volume: 10
  start-page: e0124001
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib19
  article-title: Single administration of ultra-low-dose lipopolysaccharide in rat early pregnancy induces TLR4 activation in the placenta contributing to preeclampsia
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0124001
– volume: 75
  start-page: 1020
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib20
  article-title: TLR4 activation by lipopolysaccharide confers survival advantage to growth factor deprived prostate cancer cells
  publication-title: Prostate
  doi: 10.1002/pros.22983
– volume: 13
  start-page: 19
  year: 2007
  ident: 10.1016/j.cjtee.2016.06.001_bib14
  article-title: An experimental animal model for infected wound of maxillofacial areas
  publication-title: J Hainan Med Univ
– volume: 68
  start-page: 3748
  year: 2000
  ident: 10.1016/j.cjtee.2016.06.001_bib4
  article-title: Administration of endotoxin associated with lipopolysaccharide tolerance protects mice against fungal infection
  publication-title: Infect Immun
  doi: 10.1128/IAI.68.6.3748-3753.2000
– volume: 39
  start-page: 1185
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib10
  article-title: Risk factors for incisional and organ space surgical site infections after liver resection are different
  publication-title: World J Surg
  doi: 10.1007/s00268-014-2922-3
– volume: 95
  start-page: 348
  year: 2013
  ident: 10.1016/j.cjtee.2016.06.001_bib15
  article-title: Risk factors for deep surgical site infection following operative treatment of ankle fractures
  publication-title: J Bone Jt Surg Am
  doi: 10.2106/JBJS.K.01672
– volume: 13
  start-page: 1639
  year: 2013
  ident: 10.1016/j.cjtee.2016.06.001_bib6
  article-title: Monophosphoryl lipid A is a lipopolysaccharide-derived Toll-like receptor 4 agonist which may improve Alzheimer's disease pathology
  publication-title: Expert Opin Biol Ther
  doi: 10.1517/14712598.2013.838556
– volume: 35
  start-page: 6
  year: 2015
  ident: 10.1016/j.cjtee.2016.06.001_bib3
  article-title: Role of RAGE in lipopolysaccharide-induced cytoskeletal changes in mouse pulmonary microvascular endothelial cells
  publication-title: Nan Fang Yi Ke Da Xue Xue Bao
SSID ssj0042057
Score 2.0790265
Snippet Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal...
To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal pretreatment...
Purpose:To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal...
Purpose: To assess the effects of lipopolysaccharide (LPS) pretreatment on wound infection mouse model and evaluate the biological safety of the optimal...
SourceID doaj
wanfang
pubmed
crossref
elsevier
chongqing
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 193
SubjectTerms Animals
Disease Models, Animal
Female
Inflammation - prevention & control
Inflammatory reaction
Lipopolysaccharides
Lipopolysaccharides - therapeutic use
Mice
Mice, Inbred BALB C
Rats
Rats, Wistar
Surgical wound infection
Surgical Wound Infection - drug therapy
Toll-Like Receptor 4 - physiology
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlEOiltKRN3bRBlB7r1B9j2TqmISGE0lMDuQl9JhtSO93ddun--sxI9pJASC8Fn4QtCc1Y88Z6fsPYJ0QcdWlFyAMaO4emLnIdQOZOW4NoN2AQiQTZ7-L0HM4umot7pb6IE5bkgdPCfRG6kqGQoTHeQSukaaWubWnKYMEXJiY-GPOmZCrtwVAVUeOzjOKlVdtMekOR2WWvl54UMktxkI4iSFfhaugvf2G0eBCfooz_42Fqe6X7oPvLe9Ho5CV7McJIfpim_4o98_0Om38bVtwNC8-HwG9mt1T_4O9CW_qzauY8J27hxCvnuKSc6qj8Qdt4jjCQo6-he_yMx-58nriz1MpXVHqJT7StntPXAs9jDZ3X7Pzk-MfRaT7WVMgtyG6JmaI32jpbCw8yBEwvQkDbFMaD7VxVSa2NpbfamC60rUd8hhfYCqEMYpuifsO2-qH3bxm3EtGE000ooAVt6Bddq4UrHUANYCFje5tVVbdJO0MJIbsOU6w2Y9W0zsqOcuRUFeNGTbyzaxUNpchQKrHvMvZ589DU45O3fyUDbm4lKe3YgA6mRgdT_3KwjInJ_GpEJQltYFezp0ffTc6yGR-TWzq3FRn7OHqPGneMhVpf2cV6rTx1QBtr9e5_TH6PPacOE2PxPdtazn_7D4iilmY_vjB3P0AaUA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ScienceDirect Freedom Collection 2013
  dbid: .~1
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3PaxQxFA6lIHgRxV9rVYJ4dLrzI5uZHLVYiogXLfQWkpdkO6XObHdXF_fg3-57mcxgQXoQ9rIhmyx5b977MvnyPcbeIuKoCpAhC2jsTCyqPDNBqMwZsIh2AyaRSJD9Is_OxaeLxcUBOxnvwhCtMsX-IabHaJ1a5mk156u2nX8lWRqSJ8fZ8qJRpAlK6nXo08e_J5qHKPOo9llEGVPsPSoPRY4XXG09aWUW8ng4lCCFhcu-W95g3riVqaKg_78T1r2d6YLpln_lpdOH7EEClPz98J8fsQPfPWbrz_2Ou37jeR_4dbuiSgi_NgbojlXrPCeW4cgw57i4nCqq_EQreY6AkKPXoaN8jwfwfD2waKmV76gIEx8JXB2n9waex2o6T9j56cdvJ2dZqq6QgVDNFveM3hpwUEkvVAi40QgBrZRbL6BxZamMsUDPt7VNqGuPSA0_AkoENYhy8uopO-z6zj9nHBTiCmcWIRe1MJYu64KRrnBCVEKAmLGjaVX1alDR0FKqpsHNVj1j5bjOGpIwOdXHuNYjA-1KR0NpMpQeeHgz9m760Tjind0_kAGnriSqHRv69VInr9LSlCrkKiysd6KWytbKVFDYIoDwucVB5Gh-fctHcaj27tmfDc4yzY_bXDrBlTP2JnmPTrFjo_eXsNnvtacBKMSWL_533iN2n74NfMWX7HC7_uFfIYba2tfxIfkD4_AaLg
  priority: 102
  providerName: Elsevier
Title Low dose of lipopolysaccharide pretreatment can alleviate the inflammatory response in wound infection mouse model
URI http://lib.cqvip.com/qk/85114X/201604/669889667.html
https://dx.doi.org/10.1016/j.cjtee.2016.06.001
https://www.ncbi.nlm.nih.gov/pubmed/28935116
https://d.wanfangdata.com.cn/periodical/zhcszz-e201604002
https://doaj.org/article/6a29f09f5bed4769b79a3c1b1fc4e0b1
Volume 19
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZJSqGX0NLXNu0iSo_14ocsW4cQ2tIQ-oJCF3ITkixtNmztxLvJJnvob--MbLktbAPGByOPYR6eT9LoG0LeAOLIEsNd5MDYEcuzOFKOiahSRgPadZBEfIHsN34yZZ9O89MdErqi9gpcbp3aYT-pabuY3FzeHkHAH_6p1TLnK4uclwmfdJsLu-QepKYCezl8ZcO2AktjT_2ZeE7TtMgDDdF2IUgUDOkcIIlnXjhr6tkl5JN_Mpgn-t-eyO6vVe1UPfsrXx0_JPs90KTvOs94RHZs_Zi0X5o1rZqlpY2ji_kFdki4XSqDZ6_mlaVYfRgqzykonWKnlWuwnqUAFCnoBxzop9-Yp21XXYtP6RqbM9FQ2FVTXE-w1HfZeUKmxx9_fDiJ-q4LkWGiXMFc0mplKpNxy4RzMAFxDqwXa8tMWaWpUEobjHutS1cUFhAcXMykAHYA_cTZU7JXN7V9TqgRgDcqlbuYFUxpPMRrFK-SirGMMcNG5GDQqrzo2DUk56IsYRJWjEga9CxNT1iOfTMWMlSmnUtvM4k2k1193oi8HV4KEu8c_h4NOAxFsm3_oGlnso9dyVUqXCxcrm3FCi50IVRmEp04w2ysQQgP5pc9bunwCIia3_31Z52zDN8P_jYir3vvkSEk5ObMLDcbaVEA_nrTF_99_YA8wFFdoeJLsrdqr-wrAE8rPSa7k1_J2C89wP3z93LsQ-Q3SQcX_w
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEYILAvHoUh4W4ki6eXid-AgV1QJLL7RSb5af21QlWXa3XbEHfjszjhNRCfWAlJPjeCLPZGYcf_6GkHeQcRSZ4T7xoOyETYo0UZ6JxCqjIdv1EEQCQPaYT0_Zl7PJ2Q457M_CIKwy-v7OpwdvHVvGcTbHi7oef0daGqQnB2lpVgl2h9wFWRXWbzj4PeA8WJ4Gus8s8JhC9556KIC8zMXaIVlmxg-6XQmkWDhvm_lPCBw3QlVg9P93xLq3UY1XzfyvwHT0iDyMGSX90L30Y7LjmidkOWs31LYrR1tPL-sFlkL4tVIGD1nV1lGEGfYQcwqzS7GkyjWoyVHICCmYHVjKj7ADT5cdjBZb6QarMNEewdVQ_HHgaCin85ScHn06OZwmsbxCYpio1rBodFoZawrumPAeVhreg5pS7ZipbJ4LpbTBD1zrypelg1QNLmZyyGogzUmLZ2S3aRu3R6gRkFhYNfEpK5nSeFrXKG4zy1jBmGEjsj_Mqlx0NBqSc1FVsNoqRyTv51mayEyOBTIuZQ9Bu5BBURIVJTsg3oi8Hx7qR7y1-0dU4NAVWbVDQ7ucy2hWkqtc-FT4iXaWlVzoUqjCZDrzhrlUwyC8V7-8YaQwVH279OedsQzyYZ2LW7h8RN5G65HReazk9tystlvpcAD0sfmL_5X7htyfnnybydnn46_75AHe6cCLL8nuennlXkFCtdavwwfzBwBUHUk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Low+dose+of+lipopolysaccharide+pretreatment+can+alleviate+the+inflammatory+response+in+wound+infection+mouse+model&rft.jtitle=Chinese+journal+of+traumatology&rft.au=Wang%2C+Dong&rft.au=Liu%2C+Yang&rft.au=Zhao%2C+Yan-Rui&rft.au=Zhou%2C+Jun-Lin&rft.date=2016-08-01&rft.issn=1008-1275&rft.volume=19&rft.issue=4&rft.spage=193&rft_id=info:doi/10.1016%2Fj.cjtee.2016.06.001&rft_id=info%3Apmid%2F28935116&rft.externalDocID=28935116
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85114X%2F85114X.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcszz-e%2Fzhcszz-e.jpg